Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

PaperCitations, authors & open-access status

Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 106 citations, 2017 year and bronze oa status.